Trialbee and TriNetX Partner
Trialbee, a technology provider in patient matching and engagement, is partnering with TriNetX, a global real-world health research network comprised of >170M patients across 23 countries to support data-driven digital solutions.
“This partnership will significantly widen Trialbee’s service offerings to drive patient recruitment and retention,” said Lollo Eriksson, CEO of Trialbee. “This is a great opportunity to leverage both organizations capabilities to develop new services in order to optimize clinical trials to empower patients with clinical trials as a care option. TriNetX is the market leader in leveraging real world data for the applications of clinical trial design, feasibility and site selection, and we look forward to embarking on this journey together.”
Trialbee develops innovative software to reduce clinical trial recruitment timelines and enhance the patient engagement experience, and TriNetX optimizes clinical research and enables discoveries through the generation of real-world evidence (RWE). TriNetX’s access to patients through its global healthcare organizations (HCO) partners as well as through publicly available sources, and Trialbee’s expertise in patient recruitment and digital outreach represent a multi-pronged approach to identify, engage, and drive patients to clinical trials, improving efficiency and time-to-market.
With TriNetX’s real-time access to a large data repository, patient populations, and network of HCOs, and Trialbee’s seamless patient recruitment experience, the two companies will harness the power of RWE and real-time analytics to support customers with their end goals of protocol design, site selection, patient recruitment and retention.
“Our collaboration with Trialbee further enhances our healthcare organizations’ capabilities to streamline patient identification and recruitment. We see this partnership as a complementary effort to our digital developments around protocol design, site identification and access to patients.” said Maulik Mehta, Sr. VP Corporate Development. “Together, TriNetX and Trialbee will further enable clinical research as an alternative care option to patients.”
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Grants Ziftomenib with Breakthrough Therapy Designation for NPM1-Mutant Acute Myeloid Leukemia
April 23rd 2024Data from the Phase Ib portion of the KOMET-001 trial showed that the once-daily oral treatment may provide a substantial improvement over available therapies for relapsed/refractory NPM1-mutant acute myeloid leukemia.
